Neurology News

Sleep represents a “biological necessity” that is “essential to health,” according to a position paper published by the American Academy of Sleep Medicine in Journal of Clinical Sleep Medicine.

Snoring adolescents correlated significantly with depressive symptoms and suicidality independently of sleep duration, insomnia and daytime sleepiness, according to a survey study conducted in South Korea.

More than 90% of patients in a prospective, observational study of approximately 600 experienced issues related to functional outcomes, activities of daily living, mental health and sleep 6 months after hospitalization for COVID-19.

A survey of patients with insomnia who participated in two phase 3 trials investigating daridorexant reported that “improved daytime functioning” was the most important treatment outcome for their condition.

COVID-19 infection correlated with cognitive and behavioral changes within 2 months of hospital discharge, according to findings from a small study presented during the 7th Congress of the European Academy of Neurology.

Approximately one-fifth of patients with MS exhibited a deterioration in cognitive status over 5 years, according to results of a cohort study conducted in the Netherlands and published in Neurology.

Obsessive-compulsive disorder independently increased risk for subsequent dementia, including Alzheimer’s disease and vascular dementia, according to results of a nationwide longitudinal study published in Journal of Clinical Psychiatry.

Dayvigo for the treatment of insomnia had a favorable benefit-risk ratio as assessed by three measures, according to an analysis of phase 3 trials published in Journal of Clinical Psychiatry.

TeleSleep — a telehealth program offered by the Veterans Health Administration Office of Rural Health — improved access to care for sleep-related disorders, researchers reported.

Efgartigimod, a human IgG1 antibody designed to decrease pathogenic IgG autoantibody levels, demonstrated efficacy and tolerability among patients with generalized myasthenia gravis, according to findings published in The Lancet Neurology.